Retatrutide research peptide vial — Axiom
≥99% Purity
HPLC Tested
Worldwide
Hot Selling Weight Loss

Retatrutide

Triple agonist (GLP-1/GIP/glucagon)

CODE · RT5
From €40/ vial
Research summary

Retatrutide is a triple-receptor agonist targeting GLP-1, GIP, and glucagon receptors for advanced metabolic research.

Key research highlights
  • Triple receptor activity
  • Advanced metabolic research
  • Multiple dose options

Composition & Pricing

Variant1 amp10+ amps
5mg*10vials
RT5
40.0024.00
10mg*10vials
RT10
60.0036.00
15mg*10vials
RT15
70.0042.00
20mg*10vials
RT20
90.0054.00
30mg*10vials
RT30
100.0060.00
60mg*10vials
RT60
170.00102.00

10+ ampules: −40% bulk discount applied automatically.

For research purposes only. Not for human consumption, diagnostic, or therapeutic use. Must be handled by qualified laboratory professionals.